Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Curr Hematol Malig Rep. 2014 Mar;9(1):57–65. doi: 10.1007/s11899-013-0195-9

Table 2.

Survival of MDS Patients, Aged 21 Years and Older, Post Allo HSCT Performed in the US, From 2000–2010, by Donor Type

MRD WMUD PMUD Cord blood Haploidentical p-value
N Eval 1458 1091 273 153 95 <0.001*
@ 1 year 60 (57–62) 56 (53–59) 45 (39–51) 45 (38–53) 48 (38–58) <0.001**
@ 3 years 45 (43–48) 42 (39–45) 29 (23–34) 29 (22–37) 33 (23–43) <0.001**

Unpublished data; W.S. personal communication

MRD, matched related donor; WMUD, well-matched unrelated donor [65]; PMUD, partially matched unrelated donor [65].

*

Log-rank

**

pointwise